IRIS PubliCatt

Danese, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.550
NA - Nord America 2.034
AS - Asia 699
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 2
Totale 6.297
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.020
IT - Italia 1.289
DE - Germania 1.121
SE - Svezia 381
CN - Cina 320
UA - Ucraina 289
SG - Singapore 183
IE - Irlanda 110
FR - Francia 103
GB - Regno Unito 88
ID - Indonesia 65
FI - Finlandia 57
IN - India 46
TR - Turchia 46
RU - Federazione Russa 45
JP - Giappone 14
RO - Romania 13
IR - Iran 11
CA - Canada 9
BE - Belgio 7
ES - Italia 7
NL - Olanda 7
HK - Hong Kong 6
AT - Austria 5
CH - Svizzera 5
EU - Europa 4
AU - Australia 3
BZ - Belize 3
ME - Montenegro 3
PT - Portogallo 3
BR - Brasile 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
LK - Sri Lanka 2
LT - Lituania 2
MX - Messico 2
PL - Polonia 2
SA - Arabia Saudita 2
AL - Albania 1
BG - Bulgaria 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 6.297
Salva come PNG Salva come JPEG
Città #
Chandler 418
Jacksonville 162
Ashburn 143
Singapore 143
Milan 133
San Mateo 132
Dublin 108
Rome 108
Nanjing 80
Nürnberg 78
Wilmington 71
Jakarta 65
Ann Arbor 63
Dearborn 57
Boston 51
Princeton 46
Izmir 43
Munich 40
New York 39
Redwood City 31
Woodbridge 31
Moscow 30
Nanchang 30
Turin 28
Palermo 27
Houston 25
Cattolica 22
Detroit 22
Seattle 22
Bremen 21
Hebei 20
Marseille 20
Mountain View 20
Bari 17
Lawrence 17
Shenyang 17
Los Angeles 16
Fairfield 15
Kunming 15
University Park 15
Boardman 14
Bologna 14
Changsha 14
Beijing 12
Zhengzhou 12
Jiaxing 11
Naples 11
Norwalk 11
Pune 11
Tianjin 11
Castignano 10
Florence 10
Hangzhou 10
Treviso 10
Udine 10
Andover 9
Catania 9
Genoa 9
Hefei 8
Jinan 8
Leawood 8
Simi Valley 8
Augusta 7
Dallas 7
Guangzhou 7
Lancaster 7
Napoli 7
San Jose 7
Shanghai 7
Botosani 6
Brussels 6
Costa Mesa 6
Garda 6
Helsinki 6
Hong Kong 6
Kish 6
Padova 6
Pavia 6
Redmond 6
Reggio Calabria 6
Torino 6
Verona 6
Buffalo 5
Caserta 5
Catanzaro 5
Chicago 5
Ferrara 5
Frankfurt am Main 5
Fremont 5
Lanzhou 5
Messina 5
Sant'Agata di Militello 5
Toronto 5
Vicenza 5
Vienna 5
Viterbo 5
Carate Brianza 4
Fermo 4
Garbagnate Milanese 4
Genova 4
Totale 2.884
Salva come PNG Salva come JPEG
Nome #
Ruolo dei fattori psicologici nelle malattie infiammatorie croniche intestinali 1.435
A) Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. 319
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. 204
-High prevalence of celiac disease in patients with lactose intolerance 173
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 153
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 137
Early atherosclerosis in patients with inflammatory bowel disease. 135
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 135
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations. 129
-Increased carotid intima-media thickness in patients with inflammatory bowel disease 122
Pathophysiology, diagnosis and treatment of non-erosive reflux disease (NERD) 121
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 118
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 114
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication 96
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 95
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 94
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 93
-Extraintestinal manifestations in inflammatory Bowel disease. 89
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 89
A novel pathogenic role for microvasculature in inflammatory bowel disease. 86
Gender, chronic infection and myocardial infarction 85
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 84
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. 83
Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients 83
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer. 78
Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events 77
Severe liver injury associated with zafirlukast 72
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 71
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment 69
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 69
Biological therapies for inflammatory bowel disease: research drives clinics. 67
PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system. 66
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment. 62
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 61
Elevated homocysteine levels in patients with Raynaud's syndrome 60
Balanced propofol sedation administered by nonanesthesiologists: The first Italian experience 60
Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases 59
Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement 59
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 59
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 58
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial 56
-Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation 54
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 54
ag) CD40 antisense based strategy for inflammatory bowel disease: shutting down multiple cellular communication systems. 52
Inflammatory bowel diseases and psychological issues: A new approach for a systematic analysis of the academic debate 52
Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease 51
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 49
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 48
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery 48
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 45
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. 45
A) CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation. 44
Folate in gastrointestinal health and disease 42
Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease 42
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting 42
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 41
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 40
ag) Antibody to alpha4beta7 integrin for ulcerative colitis. 37
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease 36
Thrombotic complications in inflammatory bowel disease: a multifactorial etiology 35
-Antibody to alpha4beta7 integrin for ulcerative colitis 33
Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels 31
ag) Chemokines in inflammatory bowel disease. 29
High prevalence of Helicobacter priori type I virulent strains in patients with systemic sclerosis [6] (multiple letters) 27
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study 11
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial 8
Totale 6.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020482 0 0 0 0 71 81 64 31 49 44 76 66
2020/2021761 28 72 29 93 108 35 85 23 105 37 118 28
2021/2022689 48 66 19 49 32 18 17 127 27 38 113 135
2022/20231.309 146 164 101 202 95 156 66 117 154 26 42 40
2023/2024771 41 190 48 46 62 78 50 32 22 47 69 86
2024/2025370 46 38 129 52 105 0 0 0 0 0 0 0
Totale 6.371